Diagnostic Imaging Devices - Eastern Asia

  • Eastern Asia
  • The Diagnostic Imaging Devices market market in Eastern Asia is forecasted to achieve a revenue of US$7.73bn by 2024.
  • It is expected to exhibit a compound annual growth rate (CAGR 2024-2029) of 5.12%, leading to a market volume of US$9.92bn by 2029.
  • When compared globally, the United States is projected to generate the highest revenue of US$11,930.00m in 2024.
  • In Eastern Asia, Japan leads the market for Diagnostic Imaging Devices with its advanced technology and high demand for medical equipment.

Key regions: Germany, Japan, Netherlands, Spain, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diagnostic Imaging Devices market in Eastern Asia is experiencing steady growth due to increasing customer preferences for advanced medical technology, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Eastern Asia are driving the demand for Diagnostic Imaging Devices. As the population in the region becomes more health-conscious, there is a growing demand for early disease detection and accurate diagnosis. Customers are seeking advanced imaging devices that provide high-quality images, faster scanning times, and lower radiation exposure. Additionally, there is a preference for portable and compact imaging devices that can be easily transported and used in remote areas. Trends in the market are also contributing to the growth of the Diagnostic Imaging Devices market in Eastern Asia. Technological advancements, such as the development of digital imaging and 3D imaging technologies, have improved the accuracy and efficiency of diagnostic imaging. This has led to increased adoption of these devices in healthcare facilities across the region. Furthermore, there is a growing trend towards the integration of imaging devices with artificial intelligence (AI) and machine learning algorithms, which can assist in the interpretation of medical images and improve diagnostic accuracy. Local special circumstances in Eastern Asia are also playing a role in the development of the Diagnostic Imaging Devices market. The region has a large aging population, which is driving the demand for diagnostic imaging devices for age-related diseases such as cardiovascular diseases, cancer, and neurodegenerative disorders. Additionally, there is a high prevalence of chronic diseases in the region, such as diabetes and obesity, which require regular diagnostic imaging for monitoring and treatment. Underlying macroeconomic factors are supporting the growth of the Diagnostic Imaging Devices market in Eastern Asia. The region has been experiencing rapid economic growth, leading to increased healthcare spending and investment in medical infrastructure. Governments in Eastern Asia are also implementing healthcare reforms and policies to improve access to healthcare services, which includes the procurement of advanced diagnostic imaging devices. Furthermore, the region has a strong manufacturing base for medical devices, which allows for the production of high-quality imaging devices at competitive prices. In conclusion, the Diagnostic Imaging Devices market in Eastern Asia is developing due to customer preferences for advanced medical technology, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for advanced imaging devices, technological advancements, an aging population, and economic growth are driving the growth of the market in the region.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)